Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity
eLife · 2024
DOI: 10.7554/elife.92672 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2024. Verfasst von Simei Go und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, Killer Cells, Natural, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, Beatson Institute for Cancer Research, CRUK Scotland Centre.
Abstract (Originalsprache)
The immunosuppressive microenvironment in pancreatic ductal adenocarcinoma (PDAC) prevents tumor control and strategies to restore anti-cancer immunity (i.e. by increasing CD8 T-cell activity) have had limited success. Here, we demonstrate how inducing localized physical damage using ionizing radiation (IR) unmasks the benefit of immunotherapy by increasing tissue-resident natural killer (trNK) cells that support CD8 T activity. Our data confirms that targeting mouse orthotopic PDAC tumors with IR together with CCR5 inhibition and PD1 blockade reduces E-cadherin positive tumor cells by recruiting a hypoactive NKG2D -ve NK population, phenotypically reminiscent of trNK cells, that supports CD8 T-cell involvement. We show an equivalent population in human single-cell RNA sequencing (scRNA-seq) PDAC cohorts that represents immunomodulatory trNK cells that could similarly support CD8 T-cell levels in a cDC1-dependent manner. Importantly, a trNK signature associates with survival in PDAC and other solid malignancies revealing a potential beneficial role for trNK in improving adaptive anti-tumor responses and supporting CCR5 inhibitor (CCR5i)/αPD1 and IR-induced damage as a novel therapeutic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, University of Oxford, Oxford, United Kingdom.
- Experimental Medicine Division, University of Oxford, Oxford, United Kingdom.
- University of Oxford Medical School, Oxford, United Kingdom.
- Department of Biochemistry, University of Oxford, Oxford, United Kingdom.
- Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom.
- CRUK Beatson Institute, Glasgow, United Kingdom.
ORCID-Profile: Mark R Middleton, Eric O Neill
Förderung
- Cancer Research UK
- Beatson Institute for Cancer Research
- CRUK Scotland Centre
- Kidani Memorial Trust
- NIHR Oxford Biomedical Research Centre
- Pancreatic Cancer UK
Zitieren
APA
Go, S., Demetriou, C., Valenzano, G., Hughes, S., Lanfredini, S., Ferry, H., Arbe-Barnes, E., Sivakumar, S., Bashford-Rogers, R., Middleton, M. R., Mukherjee, S., Morton, J., Jones, K., & Neill, E. O. (2024). Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. eLife. https://doi.org/10.7554/elife.92672
Vancouver
Go S, Demetriou C, Valenzano G, Hughes S, Lanfredini S, Ferry H, et al. Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity. eLife. 2024. doi:10.7554/elife.92672
BibTeX
@article{Go2024,
author = {Go, Simei and Demetriou, Constantinos and Valenzano, Giampiero and Hughes, Sophie and Lanfredini, Simone and Ferry, Helen and Arbe-Barnes, Edward and Sivakumar, Shivan and Bashford-Rogers, Rachel and Middleton, Mark R and Mukherjee, Somnath and Morton, Jennifer and Jones, Keaton and Neill, Eric O},
title = {Tissue-resident natural killer cells support survival in pancreatic cancer through promotion of cDC1-CD8 T activity},
journal = {eLife},
year = {2024},
doi = {10.7554/elife.92672}
}
EUVIMED